Inovio Extends Cash Runway to Q1 2027 Ahead of INO-3107 PDUFA Date
Inovio Pharmaceuticals confirms financial runway through Q1 2027 as its lead drug candidate nears October 2026 regulatory decision. Inovio Pharmaceuticals announced its cash runway will extend into Q1 2027, providing financial stability as it advances INO-3107 toward a reg